Updates

We bring together news, announcements and other updates from around Global Fund in this section. You can receive a notification every time a new update is published by using our really simple syndication (RSS) feed. See our RSS Feeds page for more information.

  • 08 December 2022
    Updates on the Protection from Sexual Exploitation, Abuse and Harassment (PSEAH)
    People will not access health care services if they fear that doing so will result in sexual exploitation, abuse, or harassment. Our goal of eliminating HIV, tuberculosis and malaria depends on the delivery of people-centered services that are freely...
  • 08 December 2022
    Insecticide Treated Nets: Procurement Requirements
    The Global Fund secretariat has developed and published two Briefing Notes to support Principal Recipients (PRs) in complying with the Quality Assurance requirements for the procurement of Insecticide Treated Nets.
  • 06 December 2022
    C19RM Extension, Reinvestments and Portfolio Optimization
    Over the last 6 months as the COVID-19 pandemic evolved, the Global Fund observed a shift in funding priorities in implementing countries, from emergency pandemic response to strengthening systems for health, pandemic preparedness, and recovery of HI...
  • 30 November 2022
    TERG: Evaluation of Accelerating the Equitable Deployment of and Access to Innovations
    The Technical Evaluation Reference Group (TERG) evaluated how the Global Fund is performing on accelerating the equitable deployment of and access to innovations, and how its investments complement the work of other global health partners.
  • 19 October 2022
    Opportunity for Evaluation of Diagnostic Products
    The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD).
  • 14 October 2022
    PAXLOVID Now Available Through Global Fund Support
    The new COVID-19 oral antiviral medicine nirmatrelvir/ritonavir, better known as PAXLOVID, is now available to be procured through Global Fund support.
  • 14 October 2022
    CCM Evolution: New Integrated Performance Framework
    The Global Fund is introducing a new Integrated Performance Framework for Country Coordination Mechanisms (CCMs), Principal Recipients (PRs) and Local Fund Agents (LFAs) to to strengthen CCMs annual performance and eligibility against criteria 3-6 in...
  • 14 October 2022
    CCM Evolution eLearning Course
    The Global Fund has launched a new eLearning course for Country Coordination Mechanisms (CCMs), Principal Recipients (PRs) and Local Fund Agents (LFAs) to strengthen program implementation. The course consists of four modules corresponding to the CCM...
  • 14 October 2022
    Updated Emergency Fund Guidelines
    The Global Fund Emergency Fund continues supporting eligible applicants sustain the provision and continuity of essential prevention, testing and treatment services for HIV, tuberculosis and malaria during emergency situations.   As part of ongoing ...
  • 14 October 2022
    Achieving Global Goals Together
    Following the Global Fund’s Seventh Replenishment, the Global Fund convened a high-level roundtable entitled “Achieving Global Goals Together”. The event brought together leadership of Country Coordinating Mechanisms and Principal Recipients for an ...